ADVERTISEMENT
Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
September 2023
View This Issue
Archives
Features
Quarterly Magazine
Current Issue
Fall 2023
View This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Webinars
ADVERTISEMENT
Home
Subjects
stock market
stock market
Was a Drop in CRISPR Firms’ Stock Warranted?
Claire Asher
| Jun 7, 2017
| 4 min read
A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.
Another CRISPR Biotech Goes Public
Bob Grant
| Sep 12, 2016
| 1 min read
CRISPR Therapeutics, the company started by a pioneer of the gene editing technology, plans to raise $90 million from an initial public offering.
Biotech Stocks Take a Hit
Kerry Grens
| Sep 30, 2015
| 2 min read
Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.
Biotech Terminates IPO
Jyoti Madhusoodanan
| Aug 14, 2014
| 2 min read
The Israeli firm Vascular Biogenics withdrew its initial public offering after six days of trading.
New Year’s Biotech IPO Boom?
Tracy Vence
| Feb 3, 2014
| 1 min read
January was a profitable month for biotech companies going public, Burrill & Company says.
Week in Review: August 26–30
Tracy Vence
| Aug 30, 2013
| 3 min read
New model for neurodevelopment; more biotechs going public; how a virus jumped from mammals to birds; statin side effect linked to genetic variant
Biotech IPOs Surge
Kerry Grens
| Aug 22, 2013
| 5 min read
The drought has ended for biotech companies seeking to join the public market, but whether this upward swing will last is anybody’s guess.
Financial Foraging
Beth Marie Mole
| Feb 4, 2013
| 3 min read
Using evolutionary animal behavior theories, researchers find daytime stock traders’ strategies are maladapted.
Betting on Biotech
Scott Veggeberg
| Apr 5, 1993
| 10 min read
Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.
ADVERTISEMENT